Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 12 of 31
Caregiver Speaks: A Technologically Mediated Storytelling Intervention
NCT04103580
Telemedicine Control Tower for the Post-Anesthesia Care Unit
NCT04020887
Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery
NCT04230681
Intraarticular Antibiotic in TKA
NCT04297631
Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer
NCT04162665
Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes
NCT04079881
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
NCT03956056
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
NCT04217057
Formal Pre-Operative Education
NCT04401891
Auditory Nerve Test System During Vestibular Schwannoma Resection
NCT04241679
Cognitive Changes With Gabapentin Treatment
NCT04106011
Diabetes/ Endocrine Surveillance in SDS
NCT04275479
EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer
NCT04159025
Increasing Optimal Use of HPV Vaccination in Primary Care
NCT04180462
LRTI vs Internal Brace for CMC OA
NCT03971188
Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation
NCT03388008
Combined Eating Disorder and Weight Loss Online Guided-Self Help Intervention
NCT04248686
Lenalidomide Adherence in Older Adults
NCT03779555
Mapping Draining Lymph Nodes in CNS Malignancies
NCT04096716
Sleep Apnea and Fetal Growth Restriction
NCT04084990
An Interactive Video Educational Tool Improves the Quality of Bowel Preparation for Colonoscopy
NCT04491565
Pilot Study of Same-session MR-only Simulation and Treatment With Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine
NCT03878485
Feasibility and Effect of a Strategy-Based Cognitive Intervention for Parkinson Disease
NCT04048122
Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
NCT04133415
Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and Surgery
NCT03916796
Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis
NCT03963375
Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
NCT04139018
Multi-arm Optimization of Stroke Thrombolysis
NCT03735979
Healthy Hip Study: Conservative Management for Pre-arthritic Hip Disorders
NCT04069507
Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis
NCT03903640
Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations
NCT04162847
Electronic Health Record-Enabled Evidence-Based Smoking Cessation Quality Improvement Implementation Program
NCT04107857
Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling
NCT03946774
Trial of PCIT-ED in School for Preschoolers in Poverty
NCT04399629
Dental Appliance for Parkinson's Disease
NCT04082663
Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers
NCT03843424
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
NCT03755414
Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device
NCT04008537
Cardiac and Renal Biomarkers in Arthroplasty Surgery
NCT03940651
Improvisational Dance for Parkinson Disease
NCT04354298
Speech Recognition Training in Children With Hearing Loss
NCT04041440
Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia
NCT04409041
Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension
NCT03640312
Fiber Blends and Gut Microbiota (FB)
NCT04101344
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
NCT03380351
Diastolic Hyperemia Free Index for Assessment of Moderate Coronary Stenoses
NCT04019535
IV Lidocaine in Pediatric AIS
NCT03893318
A Self-Directed Mindfulness Meditation Intervention in Gynecologic Cancer Patients
NCT04072406
Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
NCT03199040
Cognitive Flexibility Training for Persistent Pain: Neuroimaging Pilot (COFLEX-i)
NCT03720821
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.